
|Videos|May 10, 2018
Drug offers hope in treating ocular melanoma
Author(s)Richard Carvajal, MD
Richard Carvajal, MD, associate professor at Columbia University Medical Center, discusses one drug potential to treat ocular melanoma at ARVO 2018 in Honolulu.
Advertisement
The views expressed here belong to the author. They do not necessarily represent the views of Optometry Times or UBM Medica.
Richard Carvajal, MD, associate professor at Columbia University Medical Center, discusses one drug potential to treat ocular melanoma at ARVO 2018 in Honolulu.
Newsletter
Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Optometry Times - Clinical News & Expert Optometrist Insights
1
Ortho-k: More than meets the eye to control myopia progression
2
Spotlight on human trafficking: A virtual epidemic in the US
3
Drs Kaleb Abbott, Andrew Pucker suggest changing "artificial tear" terminology
4
ONL Therapeutics reports positive phase 1b data for xelafaslatide in GA
5














































.png)


